sr 95531 has been researched along with lormetazepam in 2 studies
| Studies (sr 95531) | Trials (sr 95531) | Recent Studies (post-2010) (sr 95531) | Studies (lormetazepam) | Trials (lormetazepam) | Recent Studies (post-2010) (lormetazepam) |
|---|---|---|---|---|---|
| 610 | 0 | 209 | 191 | 83 | 20 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Schneider, HH; Stephens, DN; Zimmermann, LN | 2 |
2 other study(ies) available for sr 95531 and lormetazepam
| Article | Year |
|---|---|
Partial GABA agonist activity of SR 95531 on the binding of [35S]TBPS, [3H]DMCM and [3H]lormetazepam to rat brain membranes.
Topics: Animals; Anti-Anxiety Agents; Benzodiazepines; Brain; Bridged Bicyclo Compounds; Bridged Bicyclo Compounds, Heterocyclic; Bridged-Ring Compounds; Carbolines; GABA Antagonists; gamma-Aminobutyric Acid; In Vitro Techniques; Lorazepam; Male; Pyridazines; Rats; Rats, Inbred Strains; Receptors, GABA-A | 1989 |
Binding characteristics reveal partial GABA agonist activities of SR 95531.
Topics: Animals; Anti-Anxiety Agents; Benzodiazepines; Brain; Lorazepam; Pyridazines; Rats; Receptors, GABA-A | 1989 |